1 results match your criteria: "Centre for Cancer Biology-SA Pathology and University of Adelaide[Affiliation]"
Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells.
Haematologica
May 2010
Myeloma Research Program, Division of Haematology, Centre for Cancer Biology-SA Pathology and University of Adelaide, Australia.
Background: Multiple myeloma is an incurable malignancy of bone marrow plasma cells. Progression of multiple myeloma is accompanied by an increase in bone marrow angiogenesis. Studies from our laboratory suggest a role for the CXCL12 chemokine in this process, with circulating levels of CXCL12 correlating with bone marrow angiogenesis in patients with multiple myeloma.
View Article and Find Full Text PDF